ORPOF Message Board Post 10030184 | OSE Immunotherapeutics...
home / stock / orpof / orpof message board
Dyami
(investorshub)
Posted on: May/26/2021 08:40:58
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=164030494
https://www.globenewswire.com/news-release/2021/05/26/2236023/0/en/OSE-Immunothe
News, Short Squeeze, Breakout and More Instantly...
OSE Immunotherapeutics SA Company Name:
ORPOF Stock Symbol:
Market:
-
Boehringer Ingelheim and OSE Immunotherapeutics advance clinical development of first-in-class SIRP cancer immunology treatment BI 770371 Ingelheim, Germany and Nantes, France, 3 July 2024 – Today Boehringer Ingelheim and OSE Immunotherapeutics SA (OSE), a clinical stage ...
-
OSE Immunotherapeutics Announces Publication of Preclinical Efficacy Results with Lusvertikimab in Acute Lymphoblastic Leukemia in the Journal ‘Blood’ Nantes, France – July 1 st , 2024 – 7:30 am CET – OSE Immunotherapeutics SA (ISIN: FR...
-
OSE Immunotherapeutics Announces Commercial and Revenue Sharing Agreement in the Field of CAR T-cell Therapies NANTES, France, June 24, 2024 – 7:30am CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) , today announced that the Company has entered into a commercial ...